Celldex Therapeutics shares owned by Kennedy Capital Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Kennedy Capital Management
from 13F filings
Historical chart of Kennedy Capital Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Kennedy Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Kennedy Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $11M | 352k | 31.72 |
| 2024-03-31 | $1.4M | 34k | 41.97 |
| 2023-12-31 | $2.5M | 62k | 39.66 |
| 2023-09-30 | $2.4M | 87k | 27.52 |
| 2023-06-30 | $3.0M | 87k | 33.93 |
| 2023-03-31 | $2.9M | 81k | 35.98 |
| 2022-12-31 | $3.6M | 81k | 44.57 |
| 2022-09-30 | $2.3M | 81k | 28.11 |
| 2022-06-30 | $656k | 24k | 26.98 |
| 2022-03-31 | $835k | 25k | 34.06 |
| 2021-12-31 | $1.1M | 28k | 38.64 |
More positions owned by Kennedy Capital Management
View all positions for Kennedy Capital Management